Dan Niculescu‐Duvaz

Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

Paul Wan, Mathew J. Garnett, S. Mark Roe et al. · Cell · 2004 · 2.8K citations · Full text

Medicine, Molecular Biology, Oncology +14

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Medicine, Dermatology, Oncology +13

B-RAF is a therapeutic target in melanoma

Maria Karasarides, Antonio Chiloeches, Robert Hayward et al. · Oncogene · 2004 · 433 citations

Medicine, Cancer Biology, Oncology +12

Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden et al. · Cancer Discovery · 2012 · 373 citations · Full text

Medicine, Oncology, Pharmacology +17

V599EB-RAF is an Oncogene in Melanocytes

Claudia Wellbrock, Lesley Ogilvie, Douglas Hedley et al. · Cancer Research · 2004 · 342 citations

Medicine, Cell Biology, Oncology +17